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Abstract
Background: Neutrophils leave the bone marrow as terminally differentiated cells, yet little is
known of the influence of nicotine or other tobacco smoke components on neutrophil
differentiation. Therefore, promyelocytic HL-60 cells were differentiated into neutrophils using
dimethylsulfoxide in the presence and absence of nicotine (3-(1-methyl-2-pyrrolidinyl) pyridine).
Differentiation was evaluated over 5 days by monitoring terminal differentiation markers (CD11b
expression and formazan deposition); cell viability, growth phase, kinetics, and apoptosis; assessing
cellular morphology and ultrastructure; and conformational changes to major cellular components.
Key neutrophil effector functions (oxidative burst, bacterial killing, matrix metalloproteinase
release) were also examined.
Results: Nicotine increased the percentage of cells in late differentiation phases (metamyelocytes,
banded neutrophils and segmented neutrophils) compared to DMSO alone (p < 0.05), but did not
affect any other marker of neutrophil differentiation examined. However, nicotine exposure during
differentiation suppressed the oxidative burst in HL-60 cells (p < 0.001); inhibited bacterial killing
(p < 0.01); and increased the LPS-induced release of MMP-9, but not MMP-2 (p < 0.05). These
phenomena may be α-7-acetylcholine nicotinic receptor-dependent. Furthermore, smokers
exhibited an increased MMP-9 burden compared to non-smokers in vivo (p < 0.05).
Conclusion: These findings may partially explain the known increase in susceptibility to bacterial
infection and neutrophil-associated destructive inflammatory diseases in individuals chronically
exposed to nicotine.
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Background
Tobacco smoking is a major cause of morbidity and mor-
tality. The World Health Organization recently estimated
that there are 1.1 billion current smokers [1]. As this is
equivalent to one third of the world's entire population
greater than 15 years of age, it is difficult to over-estimate
the enormity of this health problem.
Smoking causes systemic neutrophilia [2]. Multiple
tobacco-induced and/or exacerbated diseases, including
COPD [3]; atherosclerosis and other vascular diseases [4],
asthma [5], and periodontitis [6] have been associated
with neutrophil influx, cytokine release, and degranula-
tion events. Furthermore, neutrophils are key cells in com-
bating microbial invasion, and smokers exhibit an
increased risk of infectious diseases [7] including invasive
pneumococcal disease [8], tuberculosis [7], meningitis, as
well as exhibiting increased risk of infection with Helico-
bacter pylori,  Porphyromonas gingivalis, Legionella pneu-
mophila and other bacterial species [6,7].
Therefore, several studies have examined the influence of
tobacco smoke, smoke extracts, and components of
tobacco smoke on important aspects of neutrophil func-
tion, including neutrophil chemotaxis and recruitment
[9], oxidative burst [10], bacterial killing clearance
[11,12]; apoptosis [13]; and clearance of apoptotic neu-
trophils by macrophages [14]. Convincing evidence now
exists that tobacco smoke is a key stimulator of aberrant
neutrophil activation, which may predispose to several
inflammatory diseases [2,6,15].
Neutrophils leave the bone marrow as terminally differen-
tiated cells with low transcriptional activity that, without
appropriate inflammatory stimuli, normally have a short
life span of one to two days. Therefore, many important
tobacco-induced alterations to neutrophil physiology
may occur before neutrophils even reach the systemic cir-
culation. However, there are essentially no data available
on the effects of tobacco smoke or smoke products on
neutrophil differentiation.
Cigarette smoke contains more than 4000 different com-
pounds, many of which are toxic and/or bioactive. Studies
that use whole smoke or smoke extracts may better reflect
in vivo complexities. However, one major disadvantage of
using complex mixtures of smoke components approach
is that we still do not know which exact molecule(s) is
responsible for the pathological changes so that a targeted
therapeutic approach can be designed. Nicotine (3-(1-
methyl-2-pyrrolidinyl) pyridine) is a principle, toxic com-
ponent of tobacco smoke and both primary neutrophils
and HL-60 cells are known to express nicotine receptors.
Indeed, the numbers of nicotinic receptors expressed by
human neutrophils have been reported to be increased in
smokers and decline on cessation [16]. In the venous
blood of tobacco smokers, nicotine concentrations are
normally 0.5 × 10-7 M to 5.0 × 10-7 M, with arterial and tis-
sue nicotine concentrations up to six to ten-fold or two to
three-fold higher, respectively [17]. Levels of nicotine in
the oral and pulmonary environments are higher still.
Although multiple nicotine delivery systems, such as gum,
patch, and spray, have been widely used for the therapeu-
tic purpose of smoking cessation in clinic and daily life,
the continuous intake of nicotine has been reported to
hinder the functional recovery of neutrophils in smokers
who were quitting cigarettes [18].
HL-60 cells are a well-characterized promyelocytic cell
line obtained from an individual with acute promyelo-
cytic leukemia and are commonly used as a model in
granulocyte differentiation studies. As our initial data
showed that HL-60 cells express nicotinic receptors,
because nicotine is a major component of tobacco smoke
that is distributed throughout the body, and because the
study of individual tobacco components allows a more
efficient targeting of specific pathogenic mechanisms, we
determined to examine the influence of physiologically
relevant nicotine concentrations (10-7 to 10-4 M) on HL-
60 promyelocytes that were induced to differentiate into
the neutrophil lineage with dimethylsulfoxide (DMSO).
We report in this manuscript that while nicotine does not
influence HL-60 proliferation, viability, cell cycle,
ultrastructural characteristics and the expression of termi-
nal differentiation markers, key effector functions, includ-
ing superoxide generation, bacterial killing and MMP-9
release, are dysregulated.
Results
Expression of nicotinic receptors by HL-60 cells
Antibodies against nicotinic acetylcholine receptor α7
subtype bound to a HL-60 protein with a 55 kDa relative
molecular mass, as shown in Figure 1A. Both undifferen-
tiated and DMSO differentiated HL-60 cells expressed the
55 kDa receptors. Differentiation with DMSO increased
the expression of α7 nAChR, as determined by densito-
metric analysis, whereas nicotine did not. Immunofluo-
rescence revealed that α7 nAChR appears equally
distributed on the HL-60 cell surface (Figure 1B).
Cellular morphology and ultrastructure
Myeloblasts, promyelocytes and myelocytes were consid-
ered early differentiation phases. Metamyelocytes, banded
neutrophils and segmented neutrophils were considered
late differentiation phases. In the absence of DMSO, HL-
60 cells were predominantly typical promyelocytes with
large round or oval nuclei, each containing 2–4 nucleoli
and dispersed, fine nuclear chromatin. The cytoplasm was
basophilic with prominent azurophilic granules. The ratio
of nucleus/cytoplasm was relatively high (3:1 to 2:1).BMC Cell Biology 2008, 9:19 http://www.biomedcentral.com/1471-2121/9/19
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DMSO-induced HL-60 cells exhibited smaller cell size,
decreased ratio of nucleus/cytoplasm, fewer prominent
cytoplasmic granules, marked reduction or disappearance
of nucleoli, pyknotic changes in nuclear chromatin, and
notable indentation, convolution, and segmentation of
the nuclei (Figure 2A–D). These morphologic data are
consistent with the pioneer studies on the HL-60 cell line
by Collins et al [19].
The spontaneous myeloid differentiation rate of DMSO-
untreated HL-60 cells into myelocytes, metamyelocytes,
band cells and mature, segmented neutrophils remained
stable [7.1 ± 1.5%; (mean, s.d.)], regardless of nicotine
exposure (Figure 2E). Similarly, nicotine had no statisti-
cally significant influence on the percentage of HL-60 cells
differentiating past the promyelocytic stage (Figure 2E).
However, nicotine (10-4 M) increased the percentage of
cells in late phases of differentiation compared to DMSO
alone (Figure 2F).
The ultrastructural characteristics of HL-60 cells following
exposure to nicotine (10-7 -10-4M) are shown in Figure 3.
While DMSO-induced profound ultrastructural changes
over five days in the promyelocytic HL-60 cell line (Figure
3A and 3B), co-exposure to nicotine did not induce qual-
itatively observable changes in ultrastructure (Figure 3B–
D).
Cell proliferation and viability
Cellular proliferation progressed rapidly over five days in
undifferentiated promyelocytes, but was significantly
reduced gradually following DMSO induction (reduced
cell density and cell viability, as determined by trypan
blue exclusion; both p < 0.001, n = 8, data not shown).
However, proliferation of DMSO-induced or -uninduced
cells was entirely unaffected by nicotine.
Nitroblue tetrazolium reduction and expression of CD11b 
(αM integrin) by HL-60 cells
While DMSO treatment dramatically increased the per-
centage of HL-60 cells capable of reducing NBT (mean,
s.d: 6.1% at baseline; 83.3% at day 5, n = 6) and express-
ing CD11b (mean, s.d: 6.2% at baseline; 88.7% at day 5,
n = 4) over the five days of differentiation. However, nei-
ther terminal differentiation marker was affected by nico-
tine exposure (data not shown).
Cellular conformational changes
Fourier-Transform infrared spectroscopy (FT-IR) revealed
qualitative alterations to the relative IR band intensities of
lipid and DNA signals, and to the ratios of protein (amide
I: amide II) and DNA: amide II noted in 5 day cultures of
undifferentiated HL-60 cells exposed to nicotine (Figure
4A) and 5 day DMSO-differentiated HL-60 cell cultures
(Figure 4B). These specific molecular and sub-molecular
Promyelocytic and DMSO-differentiated HL-60 cells express  α7-acetylcholine nicotinic receptors Figure 1
Promyelocytic and DMSO-differentiated HL-60 cells 
express α7-acetylcholine nicotinic receptors. (A) α7 
nAChR Western blot: Lane 1. Mouse frontal brain extract 
(10 μg; positive control); Lane 2. Lysate (40 μg) of promyelo-
cytic HL-60 cells; Lanes 3 to 5. Lysate (40 μg) of five day, 
DMSO-induced HL-60 cells without nicotine, or with 10-6 M 
nicotine, or with 10-4 M nicotine treatment, respectively. α7 
nAChR-specific antibodies (Santa Cruz SC-5544) bound to 
protein bands exhibiting a relative molecular mass of 55.0 
KDa in all lanes. Densitometric analysis (data not shown) 
revealed that α7 nAChR-specific band intensities were signif-
icantly increased in the DMSO-treated samples, relative to 
promyelocytic cells (n = 5, *p < 0.05), but that this differenti-
ation-associated increase α7 nAChR protein level was not 
influenced by nicotine exposure during differentiation in any 
statistically significant manner. (B) α7 nAChR Immunofluo-
rescence staining (×1000): Fixed five-day, DMSO-induced 
HL-60 cells were incubated with a polyclonal rabbit anti-α7 
antibody (Santa Cruz SC-5544) before staining with a FITC-
conjugated anti-rabbit antibody (Santa Cruz SC-2253). α7 
nAChR-specific staining was evenly distributed across the 
cells. A similar cellular distribution of α7 nAChR was 
observed in promyelocytic cells (data not shown). (C) Nega-
tive control for α7 nAChR Immunofluorescence staining 
(×1000).
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Nicotine increases the percentage of cells reaching late stage differentiation but not other morphological characteristics of  DMSO-induced HL-60 cells Figure 2
Nicotine increases the percentage of cells reaching late stage differentiation but not other morphological 
characteristics of DMSO-induced HL-60 cells. (A – D) Hema 3 staining of differentiating HL-60 cells: Promyelocytic HL-
60 cells (A) were induced to differentiate 1.25% (v/v) DMSO over one (B), three (C), or five (D) days. Compared to undiffer-
entiated HL-60 cells, the morphological characteristics of differentiating cells include reduced cell size, decreased nucleus/cyto-
plasma ratio, disappearance of nucleoli, transformation of nuclei, and fewer cytoplasmic granules. Images were taken on an 
Olympus BX41 microscopy with a magnification of 400× using a SONY 4.1 MP digital camera. p: promyelocytes; mc: myelo-
cytes; mm: metamyelocytes; b: band cells; s: segmented neutrophil. The bars represent 10 μm. (E) DMSO exposure increased 
the mean percentage of cells differentiating beyond the promyelocytic stage over five-days, compared to DMSO-untreated 
control cells (n = 6, *p < 0.001); but nicotine had no statistically significant influence on the percentage of DMSO-treated HL-
60 cells differentiating past the promyelocytic stage. (F) DMSO exposure increased the mean percentage of cells in late phases 
of differentiation (metamyelocytes, banded neutrophils and segmented neutrophils) after 5-days compared to DMSO-
untreated control cells (n = 6, *p < 0.001); with nicotine (10-4 M) exposure during DMSO-induced differentiation further 
increasing the percentage of late phase cells compared to DMSO alone (n = 6, ¶p < 0.05). Error bars represent standard devi-
ations of the mean.
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profile alterations are indicative of pro-apoptotic changes,
as suggested by Zhou et al. [20] who have investigated the
IR spectroscopic alterations of apoptotic HL-60 cells sub-
jected to anti-tumor drug induction.
Specifically, Figure 4A shows the mean spectra of HL-60
cells from undifferentiated HL-60 cell cultures (5 days)
and those culture cells treated with nicotine after band
narrowing by Fourier self-deconvolution (bottom) and
the difference spectrum generated by subtracting the
mean spectrum of control cells from that of nicotine
treated cells (top). After Fourier self-deconvolution, one
can readily observe previously overlapping components
in the amide I band such as α-helix (1 657 cm-1), or par-
allel and antiparallel β-sheets (1 640 and 1 680 cm-1
respectively). From the difference spectrum that was gen-
erated by the integration of three individual IR experi-
ments, one can observe that the contents of α-helix,
parallel and antiparallel β-sheets in the undifferentiated
HL-60 cell cultures treated with nicotine has increased
compared to that in the control group. This observation
suggests that the different secondary protein structure in
the two groups of mean spectra reflects an altered protein
profile in nicotine-treated cells due to pro-apoptotic
changes suggested by the increased β-sheets components
[20]. Similar changes were found in nicotine treated
DMSO-differentiated HL-60 cells, as shown in Figure 4B.
Cell cycle and apoptosis
While infrared spectroscopy revealed that nicotine
induced pro-apoptotic stresses in promyelocytic and
DMSO-differentiated HL-60 cells (Figure 4), nicotine did
not promote commitment to apoptosis in undifferenti-
ated and DMSO-stimulated HL-60 cells, as determined by
flow cytometry. The percentage (mean, s.d.) of apoptotic
cells in 5-day promyelocytic cultures were 6.7 (0.4), 6.7
(0.6), and 6.3 (0.4)% for untreated control cells and those
treated with nicotine (10-6 M and 10-4M), respectively, in
four individual experiments. The percentage (mean, s.d.)
of apoptotic cells in 5-day DMSO-differentiated cultures
were 13.4 (1.1), 14.3 (3.5), and 15.8 (2.0)% for untreated
control cells and those treated with nicotine (10-6 M and
10-4M), respectively, in six individual assays. Similarly,
there were no statistically significant nicotine-induced
changes in the mean percentage of cells in the G0/G1 and
G2/M growth phases. Likewise, nicotine exerted no statis-
tically significant positive or negative effect on camp-
tothecin-induced apoptosis.
Nicotine inhibits the PMA-induced oxidative burst and 
bacterial killing in HL-60 cells
Nicotine-exposure during differentiation inhibited the
PMA-induced oxidative burst in DMSO-induced HL-60
cells in a dose-dependent manner, as shown in Figure 5.
In order to see if a reduced oxidative burst had any func-
tional relevance with respect to bacterial clearance, we
performed P. gingivalis killing assays. The ability of HL-60
cells exposed to nicotine during differentiation to kill the
Gram negative periodontal pathogen, P. gingivalis, was
compromised compared to unexposed control cells (Fig-
ure 6). This nicotine-induced suppression of bacterial kill-
ing was inhibited by α-bungarotoxin, suggestingit to be an
α7nAChR-dependent phenomenon.
Nicotine augments the release of MMP-9, but not MMP-2, 
from HL-60 cells
Nicotine-exposure during differentiation promoted the
release of MMP-9 (see Figure 7A and 7B), but not MMP-2,
from LPS-stimulated HL-60 cells. The nicotine-induced
secretion of MMP-9 was inhibited by α-bungarotoxin,
suggesting that this is an α7nAChR-dependent phenome-
non (Figure 7B).
Nicotine exposure during differentiation does not influence  the ultrastructural characteristics of HL-60 cells Figure 3
Nicotine exposure during differentiation does not 
influence the ultrastructural characteristics of HL-60 
cells. Promyelocytic HL-60 cells (A, ×1550) contain a large 
or oval nucleus (N) with diffuse chromatin, a prominent 
nucleolus (nu), and a variable number of large cytoplasmic 
vacuoles (V) some of which contain variably dense cores (d); 
Five-day, DMSO-differentiated HL-60 cells without nicotine 
treatment (B, ×2650); or exposed to 10-6 M nicotine (C, 
×4300); or 10-4 M nicotine (D, ×2650) contain a markedly 
indented and segmented nucleus with pyknotic nuclear chro-
matin (N). The nucleolus has disappeared. Small uniformly 
dense granules (dg) as well as some large vacuoles with varia-
bly dense cores (dc) were found in the DMSO-differentiated 
cells. M: mitochondria. No qualitative changes to neutrophil 
ultrastructure could be ascribed to nicotine exposure during 
HL-60 differentiation. The bars represent 1 μm.
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Characteristic IR spectra of undifferentiated (A) and differentiated (B) HL-60 cells treated with nicotine Figure 4
Characteristic IR spectra of undifferentiated (A) and differentiated (B) HL-60 cells treated with nicotine. (A) 
Fourier self-deconvoluted (FSD) mean infrared spectra of 5-day HL-60 cells treated with and without nicotine (10-6M) (bot-
tom). The difference spectrum between nicotine treated and control HL-60 cells is also shown (top). (B) Fourier self-decon-
voluted (FSD) mean infrared spectra of 5-day, DMSO-differentiated HL-60 cells treated with and without nicotine (10-6M) 
(bottom). The difference spectrum between nicotine treated and control HL-60 cells is also shown (top).
A
BBMC Cell Biology 2008, 9:19 http://www.biomedcentral.com/1471-2121/9/19
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Circulating MMP-9 in human smokers
Data collected from one female smoker was omitted from
the data analyses, as baseline cotinine concentrations did
not meet the smoking group criterion (> 20 ng ml-1). As
expected, median serum cotinine concentrations were sig-
nificantly higher in smokers compared to non-smokers
(239.1 and 0.4 ng ml-1, respectively, p < 0.001). In keep-
ing with the in vitro HL-60 data, we are able to show that
smokers exhibit a significantly higher dose of circulating
total MMP-9 than non-smokers in vivo (Figure 8).
Discussion
In addition to neutrophilia, multiple adverse effects of cig-
arette smoke on mature, circulating neutrophils have been
demonstrated. The consequences for neutrophils exposed
to tobacco smoke, or to specific tobacco smoke compo-
nents, include impaired f-actin kinetics and reduced
deformability [21], sequestration in the pulmonary
microcirculation [22], and activation in the microcircula-
tion [23]. The synthesis of superoxide has been reported
to be both increased and decreased in tobacco smoke or
nicotine-exposed neutrophils in vitro by different research
groups. However, such studies have utilized different
media for neutrophil suspensions and challenge [6]. Zap-
pacosta et al. [24] have reported that the phagocytic abil-
ity of neutrophils pretreated with aqueous smoke extracts
is hindered. Importantly, nicotine has been shown to
induce the release of elastase from human neutrophils
[25], which may play a major role in tobacco-induced
destructive diseases, such as COPD. To summarize, while
there are certainly conflicting data, it is clear that tobacco
smoking profoundly affects multiple functions of circulat-
ing and tissue neutrophils and may shift the net balance
of neutrophil activities in a destructive direction, as we
have recently reviewed [6].
There is a lack of data relating to the effect of tobacco
smoke on neutrophil differentiation in humans. It must
be acknowledged that our study model, DMSO-differenti-
ated HL-60 cells, are not entirely similar to normal neu-
trophils. However, this leukemic human cell line does
permit the reproducible study of differentiation while
retaining many of the key effector functions of primary
neutrophils, such as cytokine production, MMP release,
generation of an oxidative burst, and the ability to phago-
cytose and kill microbes. Previously, Armstrong et al. [26]
showed that five-day exposure of undifferentiated HL-60
cells to 0.06 and 0.8 μM nicotine induced a significant
increase in neutrophil elastase gene activity and protein
expression over unstimulated cells, but did not initiate
HL-60 cell differentiation. Otherwise, this study is the
first, to the best of our knowledge, to examine the effects
Nicotine suppresses Porphyromonas gingivalis killing in HL-60  cells Figure 6
Nicotine suppresses Porphyromonas gingivalis killing 
in HL-60 cells. Compared to DMSO-only control cells, nic-
otine (100 ng ml-1)-exposed five-day, DMSO-differentiated 
HL-60 cells exhibited reduced ability to kill the Gram-nega-
tive pathogen P. gingivalis (p < 0.01). This suppression of bac-
terial killing was reversed by pre-treating DMSO-induced 
HL-60 cells with the nAChR-antagonist α-bungarotoxin (α-
BTX, 500 ng ml-1). Error bars represent standard deviations 
of the mean, n = 3.
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Nicotine inhibits the oxidative burst in HL-60 cells Figure 5
Nicotine inhibits the oxidative burst in HL-60 cells. 
Compared to DMSO-only control cells, the mean oxidative 
burst (formazan deposition following PMA stimulation) 
mounted by nicotine-exposed five-day, DMSO-differentiated 
HL-60 cells was reduced by as much as 48% (n = 12, ¶¶ p < 
0.001 compared to DMSO-only control cells). Error bars 
represent standard deviations of the mean.
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of nicotine on human neutrophil differentiation. Like
Armstrong et al. [26], we noted an increase in cellular pro-
tein content by infrared spectroscopy in nicotine-stimu-
lated, undifferentiated HL-60 cells, but nicotine did not
induce differentiation in these cells [26]. In rabbits, in vivo
cigarette smoke exposure has been associated with
increased numbers of both mature and band cell (imma-
ture) neutrophils liberated from the marrow into the cir-
culation, resulting in preferential sequestration in the
microvasculature [2]. Our data shows that exposure to
nicotine during differentiation promotes late phase differ-
entiation in human HL-60 cells (Figure 2F).
Nicotine had no effect on cell growth or viability in undif-
ferentiated or differentiating HL-60 cells (Figure 4). Such
results are in keeping with the studies of Pabst et al. [12],
who have previously observed that nicotine did not affect
the viability of mature neutrophils in vitro, as determined
by trypan blue exclusion. Furthermore, our electron
microscopy studies indicate that nicotine does not influ-
ence HL-60 cell ultrastructure, relative to untreated con-
trol cells.
It has been known for some time that cigarette smoking
can induce leukocyte-endothelial adhesion, microvascu-
lar and macrovascular entrapment of leukocytes, and leu-
kocyte aggregation in humans and animal models, and
that key adhesion molecules including CD11b (a β2-
integrin chain) are central to these processes, as we have
recently reviewed [27]. We have previously examined the
influence of tobacco smoking on CD11b expression, and
other adhesion molecules, on circulating human neu-
trophils in vivo [27,28]. We found that tobacco smoking
did not acutely influence CD11b expression levels on pri-
mary neutrophils. However, Maestrelli et al. [29] have
reported that the numbers of neutrophils expressing
CD11b and CD18, but not CD11a or CD11c, are
increased in chronic smoking subjects with airway
obstruction, compared to smokers without airway
obstruction, and hypothesized that CD11b/CD18 expres-
sion by sputum neutrophils may represent a marker for
the development of chronic airway obstruction among
smokers. In the current HL-60 model, we have employed
CD11b as a marker of terminal differentiation. We noted
no statistically significant differences in CD11b expres-
sion levels in DMSO-stimulated HL-60 cells exposed to
nicotine, compared to unexposed controls. This would
imply that, within the limits of this in vitro model, any
alterations in CD11b expression profiles in chronic smok-
Tobacco smoking increases the in vivo MMP-9 burden Figure 8
Tobacco smoking increases the in vivo MMP-9 bur-
den. Total MMP-9 concentrations in the serum of smokers 
(n = 19) and non-smokers (n = 20) matched for age and gen-
der were measured by ELISA. Circulating total MMP-9 con-
centrations are significantly increased in smokers compared 
to non-smokers (* p < 0.05). Error bars represent the inter-
quartile range.
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Nicotine augments LPS-induced pro-MMP-9 release from dif- ferentiated HL-60 cells in a dose- and α7nAChR-dependent  manner Figure 7
Nicotine augments LPS-induced pro-MMP-9 release 
from differentiated HL-60 cells in a dose- and 
α7nAChR-dependent manner. (A) Gelatin Zymography: 
A representative gelatin zymogram shows increased pro-
MMP-9 (92 kDa) activity in the cell-free media (correspond-
ing to 10,000 cells) of five-day DMSO-differentiated HL-60 
cells stimulated with LPS (1.0 μg ml-1) plus nicotine (10-4 M, 
Lane 2); compared to LPS alone (Lane 1). Nicotine-induced 
augmentation of LPS-induced MMP-9 activity is abrogated by 
pre-incubation of DMSO-differentiated HL-60 cells with an 
α7-type nAChR inhibitor (α-bungarotoxin, 200 ng ml-1, Lane 
3). (B) Relative fold increases (mean, s.d.) in MMP-9 gelatino-
lytic activity were quantified by densitometry (n = 5, * p < 
0.05, ¶p < 0.01). Error bars represent standard deviations of 
the mean.
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ers are more likely to be the result of exposure of differen-
tiating neutrophils to components of tobacco other than
nicotine, or that neutrophil CD11b expression profiles are
influenced by smoke components in mature, circulating
cells rather than during differentiation. Nicotine did not
affect the other maturation marker examined, that is, for-
mazan deposition.
Neutrophils enter the circulation as terminally differenti-
ated cells. Without appropriate inflammatory stimuli,
programmed cell death is initiated rapidly. Thus, circulat-
ing neutrophils normally have a short life span of less
than a day. However, their longevity can be significantly
increased in tissues due to the suppression of apoptosis by
pro-inflammatory cytokines and other mediators [30].
Induction of apoptosis causes loss of effector function in
neutrophils, including chemotaxis, degranulation, gener-
ation of the respiratory burst, and is, thus, a key step in the
resolution of inflammation. Neutrophils that die by
apoptosis are predominantly phagocytosed and destroyed
without releasing their proteolytic arsenal [13]. However,
neutrophils that die by necrosis release degradative pro-
teases, including MMP-9, and other factors that can con-
tribute to tissue degradation. Consequently,
inappropriate suppression of apoptosis would be
expected to facilitate or potentiate neutrophil-mediated
tissue injury through prolonging neutrophil functional
lifespan and abrogating the phagocytotic clearance of
dead neutrophils.
The available evidence for an effect of tobacco smoke on
neutrophil longevity is controversial. Acrolein, a tobacco
smoke component, has been shown to suppress pro-
apoptotic signals in systemic neutrophils in an in vitro
model. Aoshiba et al. [31] reported that nicotine can sup-
press neutrophil apoptosis. A more recent report con-
cluded high nicotine doses did not influence apoptosis in
freshly isolated peripheral neutrophils [32]. Mariggio et
al. [33] have presented the alternate message, showing
nicotine to be a potent inducer of apoptosis in systemic
neutrophils, and Yoshida et al. [32] have reported that
high nicotine doses induce DNA cleavage in HL-60 cells.
Therefore, an urgent need to clarify the influence of phys-
iologically relevant nicotine exposure on apoptosis in
neutrophils has been identified.
We hypothesized that the neutrophilia noted in smokers
may partly be due to suppression of apoptosis and that
pro-apoptotic signaling may be suppressed even during
differentiation. Yet, contradicting this hypothesis, infrared
spectroscopy analysis of the molecular profiles of nico-
tine-stimulated HL-60 cells revealed apoptosis-associated
cellular alterations, including increases in the cellular
lipid content and in the DNA-protein ratio (Figure 4).
However, such pro-apoptotic influences of nicotine on
HL-60 cells during differentiation did not result in com-
mitted apoptosis, as would have been confirmed by pro-
pidium iodide staining in the flow cytometry
experiments. Furthermore, nicotine exerted no statisti-
cally significant positive or negative effect on camp-
tothecin-induced apoptosis. Clearly, definitive
conclusions on the influence of nicotine on apoptosis in
differentiating neutrophils would require the detection of
biomarkers of cell apoptosis, such as Annexin V staining,
Caspase 3 activation, and DNA fragmentation. However,
within the limits of our study, nicotine exposure during
differentiation neither promoted nor inhibited apoptosis
in our in vitro assays.
Thus, HL-60 cells are highly resistant to physiologically
relevant doses of nicotine during differentiation, with
respect to alterations to cell proliferation, viability, cell
cycle, ultrastructural characteristics and the development
of terminal differentiation markers. However, nicotine
exposure during differentiation adversely affects key effec-
tor functions in HL-60 cells. It is known that smokers
exhibit increased risk of multiple infectious diseases, as
discussed earlier. We show that the oxidative burst in
response to PMA is quantitatively diminished in HL-60
cells differentiated under the influence of nicotine (Figure
5), which is reflected in an impaired ability to kill the
Gram-negative periodontal pathogen, P. gingivalis (Figure
6). Interestingly, smokers are known to have increased
risk of P. gingivalis infections [6,34,35], to harbour greater
numbers of P. gingivalis cells [6,36] and to be more sus-
ceptible to periondontitis than non-smokers [6,37]. It
should be noted that the use of a single agent to stimulate
ROS production is a study limitation. Nevertheless, fur-
ther studies into the molecular mechanisms of nicotine-
induced suppression of the oxidative burst and bacteri-
cidal capabilities in neutrophils, are warranted.
Finally, matrix metalloproteinases are a family of at least
eighteen secreted and membrane-bound zinc-endopepti-
dases. Collectively, these enzymes can degrade most, if
not all, the components of the extracellular matrix. Neu-
trophil-derived, MMP-9-mediated tissue degradation and
the instructional role of MMP-9 in directing the inflam-
matory response are key, and perhaps critical, events in
the etiology of chronic obstructive pulmonary disease
(COPD) [38]; systemic and cerebral vascular diseases
[39], asthma [2,5], and periodontitis[6]. Tobacco smoke
exposure is the major environmental risk factor each of
these diseases, and herein we show that exposure to the
major tobacco constituent, nicotine, during HL-60 differ-
entiation exacerbates the rapid, LPS-induced MMP-9
release in a dose- and α7nAChR-dependent manner (Fig-
ure 7). MMP-2 was not similarly influenced. Engagement
of α7nAChR on other innate immune cells by nicotine, or
the endogenous α7nAChR agonist – acetylcholine, isBMC Cell Biology 2008, 9:19 http://www.biomedcentral.com/1471-2121/9/19
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known to have a profound influence on the inflammatory
response to Gram negative stimuli, as we have recently
discussed elsewhere [40]. Therefore, these data are in
keeping with, and extend, previous reports of increased
MMP-9 concentrations in the bronchoalveolar lavage flu-
ids of smoke exposed mice [41], increased neutrophil
gelatinase-associated lipocalin [NGAL: a neutrophil-
derived protein that associates with MMP-9 [42] concen-
trations in blood and bronchoalveolar lavage fluid of
smokers, compared with non-smokers [43]; and those of
Nakamura et al. [44], who were the first to suggest an
increased systemic MMP-9 load in smokers. It is not yet
clear whether this increase in the circulating MMP-9 bur-
den arises from activation of circulating neutrophils or
from translocation from inflammatory cells activated to
produce MMP-9 in the pulmonary environment. Further
studies into the mechanisms underlying nicotine-
induced,  α7nAChR-dependent augmentation of LPS-
induced MMP-9 release could allow the development of
refined and specific therapeutic strategies for the treat-
ment of a number of important tobacco-associated
inflammatory diseases and conditions.
Conclusion
This is the first in depth study of multiple aspects of neu-
trophil physiology in a consistent cell model and using
physiologically relevant nicotine dosing. While HL-60
cells are highly resistant to physiologically relevant doses
of nicotine during differentiation, with respect to altera-
tions to cell proliferation, viability, cell cycle, ultrastruc-
tural characteristics and the development of terminal
differentiation markers, key effector functions are sup-
pressed (oxidative burst and bactericidal capacity) and the
release of the MMP-9 is dysregulated. Indeed, an increased
circulating MMP-9 concentration in smokers compared to
non-smokers is also observed in vivo. These findings pro-
vide initial mechanistic insights into the increased suscep-
tibility to bacterial infection and inflammation-driven
tissue degradation known to occur in nicotine exposed
individuals. Furthermore, this study represents a timely
and extensive review of the characteristics of the common
HL-60 model of leukocyte differentiation.
Methods
Materials
HL-60 (CCL-240) and Porphyromonas gingivalis (33277)
cells were purchased from ATCC (Manassas, VA, USA).
Penicillin and streptomycin were purchased from Gibco
Laboratories (Grand Island, NY, USA). Fetal bovine serum
and Hema-3 staining kits were from Fisher Scientific
(Nepean, ON, Canada). Bromophenol blue, CaCl2, coti-
nine, Escherichia coli K12 LPS, gelatin, gentamicin,
Giemsa-Wright, metronidazole, NaCl, nicotine, nitroblue
tetrazolium (NBT), paraformaldehyde, phorbol 12-myr-
istate 13-acetate (PMA), RPMI 1640 medium, Triton X-
100, and trypan blue were bought from Sigma-Aldrich (St.
Louis, MO, USA). Glacial acetic acid, glycerol, and meth-
anol were supplied by Fisher Scientific (Ottawa, ON, Can-
ada). OsO4, Epon, lead citrate/uranyl acetate were bought
from Electron Microscopy Sciences (Hatfield, PA, USA).
Anti-α7 nicotinic acetylcholine receptor antibodies
(AChRα7 [H-302]), HRP- or FITC-conjugated goat anti-
rabbit IgG secondary antibodies, and α7 protein positive
controls (mouse frontal brain extractions) were purchased
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA,
USA). Nitrocellulose membranes were from BioRad Labo-
ratories (Mississauga, Canada). Amersham Biosciences
Corp (Piscataway, NJ, USA) enhanced chemilumines-
cence (ECL) western detection kits and x-ray films were
used for visualization of western blots. PE-conjugated
anti-CD11b (clone ICRF44) and Mouse IgG1, K (MOPC-
21) isotype control antibodies were purchased from BD
Biosciences Pharmingen (San Diego, CA, USA) and
Sigma-Aldrich (St. Louis, MO, USA), respectively. Matrix
metalloproteinase (MMP)-2, MMP-9, and Quantikine
human MMP-9 (total) immunoassays were bought from
R and D Systems (Minneapolis, MN, USA). Gifu anaero-
bic medium (GAM) broth was obtained from Nissui Phar-
maceutical Co., Ltd, Tokyo, Japan.
Subjects
The study population has been previously described [45].
Briefly, twenty smokers (10 female/10 male; 33.8, s.d. 8.8
years) and twenty age (32.6, s.d. 9.1 years) and gender
matched non-smokers were recruited from among the
patients and staff of Guy's, King's and St. Thomas' Dental
Institute and King's College London. Smokers were
required to report consumption of ≥ 10 cigarettes per day,
whereas age and gender-matched non-smokers were
required not to have smoked for ≥ 3 years. A medical his-
tory was taken for each subject and those with diabetes,
pregnancy, on anti-inflammatory drug regimens includ-
ing aspirin and other NSAID's, and with any history of
chronic inflammatory disease or leukocyte dysfunction
were excluded. Ethical approval was granted by the local
Health Research Ethics Board, and written, informed con-
sent was obtained from each subject. Serum samples from
each subject were stored at -80°C until required.
Growth of HL-60 cells
HL-60 (ATCC CCL-240) cells were cultured in RPMI 1640
medium with 0.3 g dm-3 L-glutamine and 2.0 g dm-3
sodium bicarbonate supplemented with 10% (v/v) heat-
inactivated fetal calf serum, penicillin (50 U ml-1) and
streptomycin (50 μg ml-1). The cells were cultured at 37°C
in an atmosphere of 5% CO2 and 100% humidity.
Expression of nicotine receptors by HL-60 cells
Total cell extracts (40 μg of protein) were electrophoresed
through 10% PAGE gels and transferred onto nitrocellu-BMC Cell Biology 2008, 9:19 http://www.biomedcentral.com/1471-2121/9/19
Page 11 of 14
(page number not for citation purposes)
lose membranes (0.45 μm). Membranes were blocked
with 5% milk casein. A primary polyclonal antibody
(AChRα7 [H-302], 1:200 dilution in 3% milk casein) rec-
ognizing amino acids 367–502 mapping to the C termi-
nus of α-7 subunit of the human receptor. The secondary
antibody (HRP-conjugated goat anti-rabbit IgG) was used
at a dilution of 1:1000 in 3% milk casein. Binding sites
were visualized by ECL and application to X-ray film.
Quantitation was done using Quantiscan v3.0 (Biosoft,
Cambridge, UK) with background set to correct as an
interpolated minimum. α7AChRs were also visualized by
fluorescent immunocytochemistry using primary anti-
body (AChRα7 [H-302]), a FITC-conjugated secondary
anti-rabbit IgG antibody, an inverted fluoresence micro-
scopic (Nikon Eclipse TS100 with Nikon Plan Fluor objec-
tives and Omega Optical Fluor filter set) and an inverted
confocal microscopic (Olympus IX70 with Nomarski DIC
optics). Images were captured by InCytIm 1 software
(Intracellular Imaging, Cincinnati, OH) and FluoView
software (Olympus), respectively. Control cells were
treated similarly, but without the primary antibodies.
Differentiation of HL-60 cells
Granulocytic differentiation was initiated by addition of
1.25% DMSO (final concentration) for 5 days with or
without various doses of nicotine (10-7 to 10-4 M). Multi-
ple aspects of neutrophil differentiation were monitored.
Gross morphological examination of the HL-60 cells was
performed microscopically following Hema-3 staining,
with ultrastructure characteristics examined by electron
microscopy. For electron microscopy, cells were fixed in
4% paraformaldehyde, postfixed in OsO4, dehydrated,
embedded in Epon, cut into thin sections, stained with
lead citrate/uranyl acetate and viewed on a Philips trans-
mission CM-10 electron microscope (Philips Electronics,
Eindhoven, Netherlands). The ability to reduce NBT (1.0
mg ml-1) after incubation with phorbol 12-myristate 13-
acetate (PMA, 200 ng ml-1) for 30 mins, 37°C was deter-
mined by microscopically evaluating formazan deposi-
tion in 200 randomly selected cells. The percentage of
cells in which formation of intracellular formazan depos-
its occurs increases with maturation [46]. Cell density was
measured using a hemocytometer. Viability was deter-
mined by 0.4% trypan blue staining. Expression of the ter-
minal differentiation marker CD11b was determined by
flow cytometry, as described below. Finally, the re-distri-
bution of key cellular components during differentiation
was determined by infrared spectroscopy.
Expression of CD11b (integrin αM) by HL-60 cells
Cells were stained with PE-labeled anti-CD11b mono-
clonal antibody (ICRF44 at 20 μl per 1 million cells in 100
μl total staining volume). An isotype-matched antibody
(Mouse IgG1) was used as a negative control. Data from
10000 cells were collected using an EPICS Altra-fluores-
cence-activated cell sorter (Beckton Dickinson, San Jose,
CA, USA).
Conformational changes in differentiating HL-60 cells
FT-IR spectroscopy can monitor structural alterations to
key cellular components, including membranes, proteins,
and nucleic acids. Therefore, conformational changes in
nicotine exposed differentiating HL-60 cells or unexposed
cells were examined by FT-IR spectroscopy, as described
previously [47]. Essentially, HL-60 cells were washed in
0.9% NaCl, loaded onto BaF2 windows and vacuum-dried
(25 Torr). Infrared spectra were recorded using a Bio-Rad
FTS-40A IR spectrometer (Bio-Rad Laboratories) at a nom-
inal resolution of 2 cm-1. Two separate films from each
subject sample were measured, each spectrum consisting
of 256 co-added interferograms, apodized with a triangu-
lar smoothing function before Fourier transformation. All
IR spectra were baseline corrected and area normalized
between 900 – 1800 cm-1 using WIN-IR software (Bio-Rad
Laboratories, Cambridge, MA) and analyzed using WIN-
IR and in-house FT-IR spectroscopy software (Molecular
Spectroscopy Group, National Research Council, Winni-
peg, Canada). Alterations to DNA were determined by
qualitative analysis of the DNA-specific spectral bands at
965 cm-1  (C-C/C-O stretching vibration), 1087 cm-1
(vsPO2
- stretching vibrations), 1240 cm-1 (vasPO2
- stretch-
ing vibrations), and 1713 cm-1(characteristic of base-
paired DNA strands). Qualitative lipid changes were
assessed by analysis of the spectral band at 1740 cm-
1originating from lipid ester C = O group. Qualitative
membrane protein changes were assessed by analysis of
the spectral components in the amide I band arising from
the amide C = O stretching vibration of the peptide groups
in all proteins such as α-helix (1 657 cm-1), or parallel and
antiparallel β-sheets (1640 and 1680 cm-1 respectively).
Apoptosis assays
The percentage of apoptotic cells in control and nicotine-
treated (10-4M), differentiated (5 day), HL-60 cells was
determined by propidium iodine (PI) DNA staining.
Briefly, 3.0 × 106 cells were washed in PBS, 4°C, centri-
fuged (200 × g, 5 min, 4°C), and resuspended in 0.5 ml of
cold PBS. Cells were fixed in ice cold 70% ethanol. Fixed
cells were washed in PBS, centrifuged (300 × g, 5 min,
4°C) and resuspended in cold PBS with 100 U ml-1 RNase
A and incubated at room temperature for 30 min. The
cells were further incubated in 25 μg ml-1 PI (final concen-
tration, 30 min, room temperature) in the dark. PI stain-
ing was analyzed by flow cytometery (EPICS Altra-
Fluroscence-Activated Cell Sorter). The ability of nicotine
to block camptothecin (10 μM)-induced apoptosis in dif-
ferentiated (5 day) HL-60 cells was also examined.BMC Cell Biology 2008, 9:19 http://www.biomedcentral.com/1471-2121/9/19
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Quantification of the oxidative burst
The ability of HL-60 cells, differentiated for 5 days in the
presence or absence of nicotine or cotinine, to mount an
oxidative burst in response to PMA was quantified colori-
metrically. 2 × 106 cells were treated for 1 h with 0.5 mg
ml-1 NBT and 200 ng ml-1 PMA (both final concentration),
at 37°C and the reaction stopped by adding 100% acetic
acid. After removal of supernatant (12000 × g, 2 mins,
RT), any formazan in the cell pellet was extracted using
50% acetic acid and sonication. Cellular debris was pel-
leted by centrifugation (12 000 × g, 5 mins, RT) and
reduced NBT quantified colorimetrically at 560 nm using
a Bio-Rad model 550 microplate reader (Bio-Rad Labora-
tories).
Intracellular bacterial survival assay
Porphyromonas gingivalis cultures were grown anaerobi-
cally in Gifu anaerobic medium (GAM) broth in a Coy
AALC anaerobic chamber (Coy Laboratory Products,
Grass Lake, MI, USA). Treated (nicotine differentiated)
and control 5-day, DMSO-differentiated HL-60 cells were
incubated at 37°C with P. gingivalis for one hour (MOI =
10). Extracellular, non-adherent bacteria were removed by
washing, while extracellular adherent bacteria were killed
by addition of gentamicin (300 μg ml-1) and metronida-
zole (200 μg ml-1) for one hour. After washing, internal-
ized bacteria were released by lysis of the mammalian
cells in sterile distilled water for 20 min, a treatment that
does not affect bacterial viability. Serial dilutions of the
lysates were than plated on GAM and cultured anaerobi-
cally for CFU enumeration.
Matrix Metalloproteinase (MMP) secretion
Five-day DMSO-differentiated (with or without various
doses of nicotine (10-7 to 10-4 M) were stimulated with 1.0
μg ml-1 (final concentration) purified LPS for 1 or 24 hr
and cell-free supernatants collected. The importance of
the α7 nAChR in nicotine-induced MMP-9 release was
determined by using the α7 nAChR antagonist α-BTX
(200 ng ml-1). MMP secretion was measured by gelatin
zymography and densitometry. Briefly, 20 μl aliquots of
cell-free supernatant (corresponding to 10000 cells) were
mixed with 10 μl of zymogram sample buffer (62.5 mM
Tris-HCl pH 6.8, 25% Glycerol, 4% SDS, and 0.01 %
Bromophenol Blue) and run on 8.0% SDS-polyacryla-
mide gels complemented with 0.1% gelatin type I. SDS
was removed from the gels by washing twice with 2.5%
Triton X-100, 30 min, RT, allowing the separated proteins
to renature. Subsequently, the gels were immersed into
TCS buffer (50 mM Tris-HCl, pH 7.4, 0.2 M NaCl, 5 mM
CaCl2) and incubated for 18–24 hr, 37°C then stained
with 0.25% (w/v) Coomassie Blue, 60 min, RT. Active
MMP-9 and MMP-2 were noted as clear bands against the
blue background after destaining (30 mins, RT, in 10%
glacial acetic acid and 30% methanol). MMP-9 and MMP-
2 bands were quantified by densitometry, as described
earlier.
Quantification of serum cotinine
Serum cotinine levels were determined by gas-liquid chro-
matography, as previously described [48]. Smokers can be
reliably differentiated from non-smokers by serum coti-
nine concentration at an optimal cut-off point of 13.7 ng
ml-1 [17]. Accordingly, smokers and non-smokers were
required to present with serum cotinine levels of = 20 ng
ml-1 and < 13.7 ng ml-1, respectively.
Circulating MMP-9 in smokers and non-smokers
The circulating concentrations of total MMP-9 were deter-
mined in smokers and non-smokers by Quantikine ELISA,
according to the manufacturer's instructions.
Statistical analyses
Where appropriate, statistical analysis was done by post
hoc application of Duncan's New Multiple Range Test,
assuming a significant difference at p < 0.05. Regression
lines were fitted to the raw data using SigmaPlot v7.101
(SPSS Incorporated, Chicago, ILL). Non-parametric tests
(Mann-Whitney U) were required for analyses of in vivo
cotinine and MMP-9 concentrations.
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